- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
STRATEC Biomedical AG (SBSG)
Assess today's live STRATEC Biomedical AG (SBSG) share price, performance and insights using our live Xetra: SBSG stock exchange data.
Analyse the historical data and STRATEC Biomedical AG share price performance charts on this page. Our technical summary section provides analysis on STRATEC Biomedical share price buy/sell indicators using real-time data (or discuss the STRATEC Biomedical (SBSG) stock price today with other investors in the STRATEC Biomedical ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR SBSG share price (ISIN: DE000STRA555) to enhance your trading decisions with our free investment tools and resources.
What Is the STRATEC Biomedical AG Share Price Today?
The STRATEC Biomedical share price today is 17.280.
What Is the Stock Symbol for STRATEC Biomedical AG
The stock symbol (or 'ticker') for STRATEC Biomedical AG is "SBSG."
What Stock Exchange Does STRATEC Biomedical AG Trade On?
STRATEC Biomedical AG is listed and trades on the Xetra stock exchange.
Is STRATEC Biomedical AG a Good Stock to Buy?
Determining whether STRATEC Biomedical AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and STRATEC Biomedical AG share price performance charts on this page. Our technical summary section provides analysis on STRATEC Biomedical share price buy/sell indicators using real-time data (or discuss the STRATEC Biomedical (SBSG) stock price today with other investors in the STRATEC Biomedical ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR SBSG share price (ISIN: DE000STRA555) to enhance your trading decisions with our free investment tools and resources.
What Is the STRATEC Biomedical AG Share Price Today?
The STRATEC Biomedical share price today is 17.280.
What Is the Stock Symbol for STRATEC Biomedical AG
The stock symbol (or 'ticker') for STRATEC Biomedical AG is "SBSG."
What Stock Exchange Does STRATEC Biomedical AG Trade On?
STRATEC Biomedical AG is listed and trades on the Xetra stock exchange.
Is STRATEC Biomedical AG a Good Stock to Buy?
Determining whether STRATEC Biomedical AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
17.280
-0.420(-2.37%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.160
17.540
52 wk Range
17.160
33.100
Earnings results expected tomorrow
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.16017.540
52 wk Range
17.16033.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.39%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SBSG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
28.460
Upside
+64.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Compare SBSG to Peers and Sector
Metrics to compare | SBSG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBSGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.7x | 19.5x | −0.4x | |
PEG Ratio | 0.60 | 0.04 | 0.00 | |
Price/Book | 0.9x | 1.8x | 2.6x | |
Price / LTM Sales | 0.8x | 2.1x | 3.1x | |
Upside (Analyst Target) | 67.8% | 46.0% | 56.0% | |
Fair Value Upside | Unlock | 15.4% | 9.0% | Unlock |
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 28.460
(+64.70% Upside)
Earnings
Latest Release
07/11/2025
EPS / Forecast
0.13 / --
Revenue / Forecast
57M / --
People Also Watch
FAQ
What Is the STRATEC Biomedical (SBSG) Share Price Today?
The STRATEC Biomedical stock price today is 17.280 EUR.
What Stock Exchange Does STRATEC Biomedical (SBSG) Trade On?
STRATEC Biomedical is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for STRATEC Biomedical?
The stock symbol (also called a 'ticker') for STRATEC Biomedical is "SBSG."
Does STRATEC Biomedical Pay Dividends? What’s The Current SBSG Dividend Yield?
Yes, SBSG Pays Dividends to its Shareholders. The current STRATEC Biomedical dividend yield is 3.39%.
What Is the Current STRATEC Biomedical Market Cap?
As of today, STRATEC Biomedical market cap is 210.050M EUR.
What Is STRATEC Biomedical's (SBSG) Earnings Per Share (TTM)?
The STRATEC Biomedical EPS is currently 1.263 (Trailing Twelve Months).
When Is the Next STRATEC Biomedical Earnings Date?
STRATEC Biomedical's next earnings report will be released on 30/03/2026.
Is SBSG a Buy or Sell From a Technical Analyst Perspective?
Based on today's STRATEC Biomedical moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has STRATEC Biomedical Stock Split?
STRATEC Biomedical has split 1 times. (See the SBSG stock split history page for full effective split date and price information.)
How Many Employees Does STRATEC Biomedical Have?
STRATEC Biomedical has 1420 employees.
What is the current trading status of STRATEC Biomedical (SBSG)?
As of 29/03/2026, STRATEC Biomedical (SBSG) is trading at a price of 17.280 EUR, with a previous close of 17.700 EUR. The stock has fluctuated within a day range of 17.160 EUR to 17.540 EUR, while its 52-week range spans from 17.160 EUR to 33.100 EUR.
What Is STRATEC Biomedical (SBSG) Price Target According to Analysts?
The average 12-month price target for STRATEC Biomedical is 28.460 EUR, with a high estimate of 34 EUR and a low estimate of 23 EUR. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +64.70% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.